Highlands Oncology Group Participated in Research of Hodgkin Lymphoma Which is Considered a Milestone For the Disease

NeuroQuest's blood-based biomarker test for early diagnosis of Alzheimer's disease exceeded U.S. Alzheimer's Association standards during recent pilot study in Australia. NeuroQuest has contracted with a major U.S. university to oversee collection and processing of 700 samples for their national clinical trial. The NeuroQuest blood test can potentially identify a pre-clinical stage of AD in a person years before the onset of noticeable symptoms, paving the way for new therapies and research.

Due to a strong 2011 fourth quarter and anticipated growth in the first quarter of 2012, DiaTri, the nationwide diagnostic benefit management company, has acquired three new people to expand their nationwide sales coverage.